Insights from 2023 ASH Annual Meeting

 

Insights from 2023 ASH Annual Meeting
M

ASH 2023 Insights: "Durable Clinical Benefit With KER-050 (Elritercept) Treatment in a Ph2 Study in Patients With Lower-Risk MDS"

By Insights from 2023 ASH Annual Meeting FEATURING Maria Diez-Campelo
By Insights from 2023 ASH Annual Meeting FEATURING Maria Diez-Campelo
14 views
December 14, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

26:22
Agios

Pyruvate Kinase Deficiency: An Underrecognized Cause of Chronic Hemo…

Feat. J. M. Despotovic

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi
MDS and MPN
21:52
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Imp…

Feat. D. Tremblay
10:02
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of MPNs - Highlights & Key Take…

Feat. R. Mesa
12:38
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "LIMBER-103 Study - BETi INCB057643 in Pts W…

Feat. J. Watts
08:18
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…

Feat. A. Zhou
05:44
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Study of Add-on Therapy With CK0804 in Pati…

Feat. L. Masarova
12:21
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "PIM1 Kinase Inhibitor TP-3654 for R/R Myelo…

Feat. L. Rein
11:20
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Validation of the Composite CR Definitions …

Feat. J. Bewersdorf
13:24
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "MATTERHORN Study - Efficacy & Safety of…

Feat. M. Mittelman
06:46
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Guadecitabine in Higher-Risk MDS and CMML U…

Feat. S. Urrutia
06:38
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "FREEDOM2 Study of Fedratinib in Patients Wi…

Feat. C. Harrison
10:40
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Durable Clinical Benefit With KER-050 (Elri…

Feat. M. Diez-Campelo
06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay